Asthma drug that cures severe itchy rash
Feb 24 2013, 10:08pm CST | by Luigi Lugmayr
Washington, Feb 25 (IANS) A high-dose shot of a common asthma drug, once a month, has been found to be highly effective in treating teens and adults chronically afflicted with severe, itchy rash, says a new study.
Washington, Feb 25 — A high-dose shot of a common asthma drug, once a month, has been found to be highly effective in treating teens and adults chronically afflicted with severe, itchy rash, says a...
Filed under: news
6 hours ago
New Drug May Decrease Asthma Attacks By 87%
Source:
Medical News Today |
May 22 2013, 3:52pm CDT
Editor's Choice Academic Journal Main Category: Respiratory / Asthma Article Date: 22 May 2013 - 12:00 PDT A novel, lab-made molecule was able to stick to certain inflammatory proteins and decrease and minim ...
Advertisement
6 hours ago
Family get control over their asthma
Source: Northland Northern Advocate | May 22 2013, 3:21pm CDT
A Whangarei mother of two children who both have asthma is calling on families affected by the respiratory illness to seek help from the Northland Asthma Society rather than just relying on hospitals and GPs. Wit ...
Continue reading on: Northland Northern Advocate More like this
Quote:
"I see a lot of asthma, a lot of emphysema, a lot of pneumonia ... It’s on the rise, and I think it’s largely related to pollution."
Source: Ottawa Citizen
Currently Trending
6 hours ago
Regeneron moves higher on asthma drug study data
Source:
CNBC |
May 22 2013, 3:13pm CDT
NEW YORK -- Shares of Regeneron Pharmaceuticals Inc. edged higher on Wednesday on positive clinical trial data for an experimental asthma drug. THE SPARK: The New England Journal of Medicine's website on Tuesday published the results of a stu ...
9 hours ago
New asthma drug, duplimab, cuts attacks by 87% and treats underlying cause olf asthma
Source:
Next Big Future |
May 22 2013, 12:32pm CDT
This blog is an Amazon affiliate. Help support Nextbigfuture by making purchases through Amazon links on this site. Editor/Authors are : Brian Wang, Director of Research. Sander Olson, Interviews and other articles Phil Wolff, ...
9 hours ago
Asthma drug shows promise
Source: She Knows | May 22 2013, 11:58am CDT
The new drug dupilumab shows promise to help those who suffer from uncontrollable asthma. Good news for the nearly 25 million Americans with asthma. Regeneron Pharmaceuticals is unveiling a new experimental antibody drug that has had posit ...
Recommended
12 weeks ago
Asthma drug that cures severe itchy rash
Feb 24 2013, 10:08pm CST | by Luigi Lugmayr
Washington, Feb 25 (IANS) A high-dose shot of a common asthma drug, once a month, has been found to be highly effective in treating teens and adults chronically afflicted with severe, itchy rash, says a new study.
Washington, Feb 25 — A high-dose shot of a common asthma drug, once a month, has been found to be highly effective in treating teens and adults chronically afflicted with severe, itchy rash, says a new study.
Known as omalizumab, the drug was tested on 323 people at 55 medical centres for whom standard antihistamine therapy failed to quell underlying, allergy-like reaction, known as chronic idiopathic urticaria or chronic spontaneous urticaria.
"Physicians and patients may now have a fast, safe and well-tolerated treatment option to consider before prescribing even more antihistamines, which can be highly sedating," says Sarbjit (Romi) Saini, Johns Hopkins allergist and immunologist, and study co-investigator, the The New England Journal of Medicine reports.
The study, from 2009 to 2011, involved mostly women aged between 12 and 75 years. Each was randomly assigned to take one of three dosing regimens of omalizumab, or placebo, after which they were monitored through regular checkups for four months, according to a Johns Hopkins statement.
All of them had chronic hives (itchy bumps on the skin) and rash for at least six months, with many having suffered from the condition for more than five years.
"Patients suffering with this condition need more and better treatment options because chronic hives and rash are profoundly hard to treat and can be very debilitating," says Saini, associate professor at the Johns Hopkins University School of Medicine.
Saini, who has studied omalizumab since 2005, points out that fewer than half of those treated respond to traditional drug treatments with antihistamines. Saini says the new study results offer substantial evidence that this first injection treatment option not only works, but does so more safely than other drugs.
These findings were presented at the annual meeting of the American Academy of Allergy, Asthma and Immunology in San Antonio, Texas.
IANS
Source: IANS
Don't miss ...
news
Vitamin D from sun may treat asthma, says study
2 days ago
London, May 20 (IANS) Time spent by asthma patients soaking...
news
A 'bionic eye' that gives limited vision to blind
Feb 16 2013
Washington, Feb 16 (IANS/RIA Novosti) The US Food and Drug...
Luigi Lugmayr
Luigi is the founding Chief Editor of I4U News and brings over 15 years
experience in the technology field to the ever evolving and exciting
world of gadgets. He started I4U News back in 2000 and evolved it into
vibrant technology magazine.
Luigi can be contacted directly at ml@i4u.com. Luigi posts regularly on LuigiMe.com about his experience running I4U.
blog comments powered by Disqus
Latest stories
Los Angeles, May 22 (IANS) Scientists have identified an amino acid fragment that can be used to halt cancer spread, says a study.
Washington, May 22 (IANS) Scientists have engineered nanoparticles derived from grapefruit lipids that could be used to deliver anti-cancer and other drugs to tumour cells, says a study.
Washington, May 22 (IANS/EFE) Microsoft unveiled a new Xbox console Tuesday that represents a major upgrade on the US-market-leading Xbox 360 model.
Beijing, May 22 (IANS) China has appealed for communication with the US on cyber security, Xinhua reported Tuesday.
- Visit our Homepage for the Trending Apple News.
